CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Fatal invasive Trichosporon asahii infection with exophytic bronchial lesions in a patient with lymphoma undergoing CAR T-cell therapy.
Fatal invasive Trichosporon asahii infection with exophytic bronchial lesions in a patient with lymphoma undergoing CAR T-cell therapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
真菌感染在免疫抑制患者中日益常见,非念珠菌类酵母菌如阿萨希毛孢子菌正成为重要的机会性病原体。阿萨希毛孢子菌是一种担子菌类酵母,能够在深度免疫抑制的宿主中引起播散性疾病,尤其是血液系统恶性肿瘤患者或接受细胞治疗的患者。由于与隐球菌形态相似以及传统方法敏感性有限,诊断往往具有挑战性,而治疗因对棘白菌素类药物的固有耐药以及尽管使用唑类治疗仍高死亡率而变得复杂。我们报告了一例50多岁患有难治性弥漫性大B细胞淋巴瘤并接受CAR-T 细胞治疗的女性患者中发生的致死性播散性阿萨希毛孢子菌感染。在输注后第8天,她出现低氧血症、血流动力学不稳定和急性肾衰竭,需要重症监护。支气管镜检查显示右主支气管外生性病变,从支气管肺泡灌洗液和血培养中分离出阿萨希毛孢子菌。尽管早期使用了伏立康唑治疗,患者仍死于感染性休克。
Fungal infections are increasingly observed in immunocompromised patients, with non-Candida yeasts such as Trichosporon asahii emerging as significant opportunistic pathogens. T. asahii is a basidiomycetous yeast capable of causing disseminated disease in profoundly immunosuppressed hosts, particularly those with haematological malignancies or receiving cellular therapies.
Diagnosis is often challenging due to morphological similarities with Cryptococcus and the limited sensitivity of conventional methods, while treatment is complicated by intrinsic resistance to echinocandins and high mortality despite azole therapy.
We report a fatal case of disseminated T. asahii infection in a woman in her 50s with refractory diffuse large B-cell lymphoma undergoing chimeric antigen receptor T-cell therapy. On day 8 post-infusion, she developed hypoxia, haemodynamic instability and acute renal failure requiring intensive care. Bronchoscopy revealed exophytic right main bronchial lesions, and T. asahii was isolated from bronchoalveolar lavage and blood cultures. Despite early voriconazole therapy, the patient died of septic shock.
MEMBER ACCOUNT
登录成功会直接打开下一页。